Frontiers in Medicine, 2022 PurposeTo investigate the intravitreal injection of conbercept as a treatment strategy for proliferative diabetic retinopathy (PDR) with or without center-involved diabetic macular edema (CI-DME) and evaluate its effect on the microvascular changes in ...
Wei Lin +25 more
doaj +1 more source
Comparison of efficacy of conbercept, aflibercept, and ranibizumab ophthalmic injection in the treatment of macular edema caused by retinal vein occlusion: a Meta-analysis [PDF]
International Journal of Ophthalmology, 2023 AIM: To evaluate and compare the anatomical and functional outcomes and negative effects of the three anti-vascular endothelial growth factor (VEGF) drugs in the treatment of macular edema (ME) due to retinal vein occlusion (RVO) based on the evidence ...
Qiu Xing +3 more
doaj +1 more source
Frontiers in Medicine, 2021 Background: With the advent of aging society of China, fundus diseases related to pathological neovascularization, including age-related macular degeneration (AMD), diabetic macular edema (DME), and pathological myopia (PM), have become an increasingly ...
Zhuang Cui +7 more
doaj +1 more source
Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling. [PDF]
PLoS ONE, 2013 Conbercept is a genetically engineered homodimeric protein for the treatment of wet age-related macular degeneration (wet AMD) that functions by blocking VEGF-family proteins.
Zhigang Wu +7 more
doaj +1 more source
Journal of Ophthalmology, 2021 Objective. This meta-analysis aimed to compare the effect and safety of conbercept with panretinal photocoagulation (PRP) vs. PRP in the treatment of diabetic retinopathy (DR). Methods. Relevant studies were identified through systemic searches of PubMed,
Chao Huang, Haiqing Ji, Xuguang Han
doaj +1 more source
Successful Use of Conbercept to Treat Choroidal Neovascularization: A Case Report
Case Reports in Ophthalmology, 2022 Chronic urticaria is a dermatological condition characterized by the appearance of wheals or angioedema longer than 6 weeks. It could cause serious complications such as laryngeal edema, vasculitis, and diarrhea. However, the pathologic changes of the ocular fundus caused by chronic urticaria are rarely reported.
Jin Yang, Zheng Liu, Tao Liu
openaire +3 more sources
The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy [PDF]
Journal of Ophthalmology, 2019 Purpose. To evaluate the efficacy and safety of conbercept for patients with chronic central serous chorioretinopathy (CSC). Methods. A retrospective clinical study. Thirty-one patients (35 eyes) with chronic CSC were given intravitreal injections of conbercept and followed up for at least 6 months.
Jianbo Mao +7 more
openaire +3 more sources
Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
Frontiers in Pharmacology, 2023 Purpose: Intravitreal injection of conbercept (IVC) is a novel anti-vascular endothelial growth factor (anti-VEGF) treatment for retinopathy of prematurity (ROP). This study aimed to assess the intraocular pressure (IOP) effect of IVC.Methods: All IVC surgeries were performed in the Department of Ophthalmology, Guangdong Women and Children Hospital ...
Caifeng Gao +10 more
openaire +3 more sources
One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data [PDF]
International Journal of Ophthalmology, 2019 AIM: To evaluate the real-life clinical outcomes of intravitreal injection of conbercept combined rescue therapy for polypoidal choroidal vasculopathy (PCV). METHODS: This was an open label, single center, and interventional study. All enrolled patients
Hui-Jun Qi, En-Zhong Jin, Ming-Wei Zhao
doaj +1 more source
Short-term effects of intravitreal Conbercept injection combined with laser photocoagulation on macular edema secondary to ischemic retinal vein occlusion [PDF]
International Journal of Ophthalmology, 2021 AIM: To observe changes in the best-corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) of patients with macular edema (ME) secondary to ischemic retinal vein occlusion (iRVO) following intravitreal ...
Zheng-Feng Liu +6 more
doaj +1 more source